Taken together, these findings suggest that BMD-001S may serve as a promising candidate to improve PGC-1α deficiency by modulating miR-485-3p dysregulation in a region-specific manner within the spinal cord during ALS progression caused by SOD1G93A mutation. This evidence concerns the gene PPARGC1A and amyotrophic lateral sclerosis.